Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jun 19, 2019 at 9:23 AM EDT

Why This FDA Approval for Pneumonia Treatment Is So Huge

Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA)…

Jon C. Ogg | Jun 19, 2019 at 8:53 AM EDT

One Firm Sees Up to 45% Upside in Top Companies in Life Sciences Tools

Health care stocks still have plenty of upside in them. Agilent, Danaher, Thermo Fisher are all stocks to buy.

Jon C. Ogg | Jun 18, 2019 at 2:03 PM EDT

Two Very Speculative Biotechs With Promising Alzheimer’s Treatment Hopefuls

Analyst Yun Zhong looks at two treatments for Alzheimer Disease and other dementias that could beat the odds and be…

Chris Lange | Jun 18, 2019 at 11:57 AM EDT

Tuesday’s Top BioPharma Movers Deviating from the Market

24/7 Wall St. has picked a few of those standouts from Tuesday to highlight. We have included information about each…

Chris Lange | Jun 18, 2019 at 10:22 AM EDT

How PhaseBio Pharma Could Change the Game in Antiplatelet Therapy

PhaseBio Pharmaceuticals shares jumped on Tuesday after the firm announced preliminary results from its mid-stage trial on subjects on dual…

Chris Lange | Jun 17, 2019 at 1:05 PM EDT

How Aclaris Is On Track to Treat Baldness

Baldness is something that many men fear as they age, and understandably so. But Aclaris Therapeutics may have found an…

Hristina Byrnes | Jun 17, 2019 at 12:12 PM EDT

Can This Pill Stave Off Alzheimer’s While Lowering Blood Pressure?

A blood pressure medication widely used in Europe and Japan might have potential to slow down the progress of Alzheimer’s…

Chris Lange | Jun 17, 2019 at 11:56 AM EDT

How Much Is Pfizer Overpaying For Array Bio?

Array BioPharma shares shot up on Monday after the firm announced that it would be acquired by Pfizer in an…

Douglas A. McIntyre | Jun 17, 2019 at 9:06 AM EDT

This Form of Cancer Will Kill More People Than the Most Common Cancer in 2019

Annual deaths from cancer have dropped 27% in the last 25 years, according to the American Cancer Society (ACS). However,…

Douglas A. McIntyre | Jun 15, 2019 at 7:11 AM EDT

It’s 119 Degrees In This City Now, And It’s Not Getting Better

Heat waves swung through Phoenix the week and pushed temperatures as high as 110 degrees Fahrenheit. In New Delhi, India,…

Jon C. Ogg | Jun 14, 2019 at 11:45 AM EDT

High Hopes and Expectations for Merck’s First Investor Day in Years

Merck is set to host its Investor Day on June 20. Investors will have a high bar of expectations because…

Chris Lange | Jun 14, 2019 at 9:35 AM EDT

Why ArQule’s Early-Stage Hematology Study Could Be Transformational

ArQule shares jumped early on Friday after the firm announced preliminary results from an early-stage study in patients with relapsed…

Chris Lange | Jun 13, 2019 at 10:05 AM EDT

Investors Need Some Breathing Room From Savara’s Lung Treatment

Savara shares were absolutely crushed on Thursday after the company released its late-stage results for its treatment of autoimmune pulmonary…

Jon C. Ogg | Jun 12, 2019 at 1:15 PM EDT

Multimillion-Dollar Medical Claims Continue to Skyrocket

Whether you were in favor of or against the Affordable Care Act, it is likely of little surprise that the…

Chris Lange | Jun 12, 2019 at 8:40 AM EDT

Big Biotechs Have Short Sellers on the Run

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data…

1 … 95 96 97 98 99 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why This FDA Approval for Pneumonia Treatment Is So Huge

One Firm Sees Up to 45% Upside in Top Companies in Life Sciences Tools

Two Very Speculative Biotechs With Promising Alzheimer’s Treatment Hopefuls

Tuesday’s Top BioPharma Movers Deviating from the Market

How PhaseBio Pharma Could Change the Game in Antiplatelet Therapy

How Aclaris Is On Track to Treat Baldness

Can This Pill Stave Off Alzheimer’s While Lowering Blood Pressure?

How Much Is Pfizer Overpaying For Array Bio?

This Form of Cancer Will Kill More People Than the Most Common Cancer in 2019

It’s 119 Degrees In This City Now, And It’s Not Getting Better

High Hopes and Expectations for Merck’s First Investor Day in Years

Why ArQule’s Early-Stage Hematology Study Could Be Transformational

Investors Need Some Breathing Room From Savara’s Lung Treatment

Multimillion-Dollar Medical Claims Continue to Skyrocket

Big Biotechs Have Short Sellers on the Run

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Why This FDA Approval for Pneumonia Treatment Is So Huge

One Firm Sees Up to 45% Upside in Top Companies in Life Sciences Tools

Two Very Speculative Biotechs With Promising Alzheimer’s Treatment Hopefuls

Tuesday’s Top BioPharma Movers Deviating from the Market

How PhaseBio Pharma Could Change the Game in Antiplatelet Therapy

How Aclaris Is On Track to Treat Baldness

Can This Pill Stave Off Alzheimer’s While Lowering Blood Pressure?

How Much Is Pfizer Overpaying For Array Bio?

This Form of Cancer Will Kill More People Than the Most Common Cancer in 2019

It’s 119 Degrees In This City Now, And It’s Not Getting Better

High Hopes and Expectations for Merck’s First Investor Day in Years

Why ArQule’s Early-Stage Hematology Study Could Be Transformational

Investors Need Some Breathing Room From Savara’s Lung Treatment

Multimillion-Dollar Medical Claims Continue to Skyrocket

Big Biotechs Have Short Sellers on the Run

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up